Premature conclusions on HPV-only testing – Authors' reply
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA. The Lancet Oncology
(Impact Factor: 24.69).
10/2011; 12(11):993. DOI: 10.1016/S1470-2045(11)70240-6
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.